Abstract

Simple SummaryChronic lymphocytic leukaemia (CLL) is a heterogeneous chronic disease characterised by the clonal expansion of mature CD19+CD23+CD5+ B-cells in blood, bone marrow and lymphoid tissue. Despite the CLL tumour cell population showing considerable heterogeneity in cell size, the functional characteristics of leukemic cells that differ in size have not been explored. The results of our study demonstrate that differences in CLL cell size reflect their activation state, polarisation and migratory capacity, with large CLL cells being more activated, polarised and motile than the small CLL cells present in the CLL cell pool. Our data provide evidence of the importance of cell-size heterogeneity within the CLL cell pool and the dynamics of cell-size changes for disease pathogenesis.Chronic lymphocytic leukaemia (CLL) is a genetically, morphologically and phenotypically heterogeneous chronic disease with clinical variability between patients. Whether the significant heterogeneity of cell size within the CLL population contributes to the heterogeneous features of this disease has not been investigated. The present study aimed to characterise the phenotypic and functional properties of two subpopulations of typical CLL cells that differ in cell size: small (s-CLL) and large (l-CLL) CLL cells delineated by forward scatter cytometry. The s-CLL cells were characterised by the CD5lowCXCR4hi phenotype, while the l-CLL cells were characterised by the CD5hiCXCR4dim phenotype and indicated a higher expression of CXCR3, CD20, CD38 and HLA-DR. The l-CLL cells displayed higher migration activity towards CXCL12, a tendency towards a higher proliferation rate and an increased capacity to produce IgM in the presence of CpG compared with s-CLL cells. When stimulated with CpG and CXCL12, l-CLL cells were characterised by a higher polarisation phenotype and motility than s-CLL cells. Our study revealed that the differences in CLL cell size reflected their activation status, polarisation and migratory abilities. Our data provide evidence of the importance of cell-size heterogeneity within a CLL pool and the dynamics of cell-size changes for disease pathogenesis, thus deserving further investigation.

Highlights

  • Chronic lymphocytic leukaemia (CLL) is characterised by the clonal expansion of mature CD19+CD23+CD5+ B-cells in the blood, bone marrow and lymphoid tissue [1]

  • This study aimed to analyse the biology of small (s-CLL) and large (l-CLL) CLL cells delineated by forward scatter (FSC) flow cytometry, with a primary focus on activation status, immunophenotype, proliferation, polarisation and migration

  • The immunophenotyping demonstrated that s-CLL cells were characterised by the CD5lowCXCR4hi phenotype, while l-CLL cells were characterised by the CD5hiCXCR4dim phenotype and had a higher expression of CXCR3, CD20, CD38 and HLA-DR than s-CLL cells

Read more

Summary

Introduction

Chronic lymphocytic leukaemia (CLL) is characterised by the clonal expansion of mature CD19+CD23+CD5+ B-cells in the blood, bone marrow and lymphoid tissue [1]. CLL cells are characterised by their phenotypic, clonal and functional heterogeneity and contain a pool of resting and proliferating CLL subpopulation cells [2,3,4,5,6]. The inverted expression of CD5 and CXCR4 has been indicated as useful for identifying enriched fractions among recently born/divided and elderly/quiescent CLL cells [2,3,7]. This means that the fraction of proliferating, recently born/divided migrating CLL cells has been shown to preferentially express high levels of CD5, while low levels of CD5 are associated with resting, elderly/quiescent circulating cells [3,8]. Studies have shown that CXCR4dimCD5bright ‘proliferative’ cells overexpress more ‘cell division’ genes, while CXCR4brightCD5dim ‘resting’ cells express higher levels of ‘antiproliferative’ genes, suggesting that the latter subset may represent a distinct self-renewing type from which all clonal members are derived [3,8]

Objectives
Methods
Findings
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call